JPMorgan downgrades pharma but still likes a few stocks
Published on 19/08/2025 02:49 PM
JPMorgan downgrades pharma but still likes a few stocksPharma stocks has outperformed the MSCI India Index by 40% in the last three years. However, several looming challenges threaten the momentum in many of the stocks. Scroll down for three names that the analysts continue to be bullish on.By Hormaz Fatakia August 19, 2025, 2:49:56 PM IST (Published)4 Min ReadBrokerage firm JPMorgan has adopted a more selective and cautious stance on India’s healthcare sector, downgrading the pharmaceutical space to 'underweight', citing concerns over earnings volatility, tariff risks, and a fading growth profile.Continue Reading with CNBC-TV18 Access MembershipPriority Access and Networking: CNBC-TV18's flagship events Interaction with CNBC-TV18's journalists Webinars & LIVE Q&As with India Inc. Leaders Exclusive CNBC-TV18 studio & newsroom tours Premium business insights, expert opinions & analysis Curated lifestyle privileges & offers